Assessment of Outcomes Associated With the Use of Newly Approved Oncology Drugs in Medicare Beneficiaries

IMPORTANCE: A lack of generalizability of pivotal cancer clinical trial data to treatment of older adults with Medicare could affect therapeutic decision-making in clinical practice. OBJECTIVE: To evaluate the differences in survival, duration of therapy, and treatment patterns between clinical tria...

Descripción completa

Detalles Bibliográficos
Autores principales: Green, Angela K., Curry, Michael, Trivedi, Niti, Bach, Peter B., Mailankody, Sham
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2021
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7905499/
https://www.ncbi.nlm.nih.gov/pubmed/33625507
http://dx.doi.org/10.1001/jamanetworkopen.2021.0030

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7905499/
https://www.ncbi.nlm.nih.gov/pubmed/33625507
http://dx.doi.org/10.1001/jamanetworkopen.2021.0030

Ejemplares similares